FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

10794211000001106: 3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
37134801000001118 3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
37134901000001112 3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet Is a 3,4-Diaminopyridine 20mg tablets 1 tablet true Inferred relationship Existential restriction modifier
3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet Is pack of 3,4-Diaminopyridine 20mg tablets (Small Scale Pharmaceuticals (Brighton) Ltd) false Inferred relationship Existential restriction modifier
3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet Has active ingredient Amifampridine false Inferred relationship Existential restriction modifier
3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet Has AMP 3,4-Diaminopyridine 20mg tablets (Small Scale Pharmaceuticals (Brighton) Ltd) true Inferred relationship Existential restriction modifier
3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet Has specific active ingredient Amifampridine false Inferred relationship Existential restriction modifier
3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet Has specific active ingredient Amifampridine true Inferred relationship Existential restriction modifier
3,4-Diaminopyridine 20mg tablets (Special Order) 1 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start